Sharon Mates

Insider Reports History

Entity
Individual
Location
C/O Intra Cellular Therapies, Inc., 3960 Broadway, New York, NY
Signature
/s/ John P. Condon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Mates:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intra-Cellular Therapies, Inc. Chairman and CEO, Director Common Stock 1.07M $78.5M $73.32 Aug 30, 2024 Direct
Intra-Cellular Therapies, Inc. Chairman and CEO, Director Restricted Stock Units 20.6K $1.38M $67.12 Mar 10, 2024 Direct
Intra-Cellular Therapies, Inc. Chairman and CEO, Director Stock Option (right to buy) 103K Aug 30, 2024 Direct

Insider Reports Filed by Sharon Mates

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITCI Intra-Cellular Therapies, Inc. Aug 29, 2024 8 -$4.2M 4 Aug 30, 2024 Chairman and CEO, Director
ITCI Intra-Cellular Therapies, Inc. Aug 26, 2024 11 -$5.37M 4 Aug 28, 2024 Chairman and CEO, Director
ITCI Intra-Cellular Therapies, Inc. Aug 21, 2024 13 -$6.96M 4 Aug 23, 2024 Chairman and CEO, Director
ITCI Intra-Cellular Therapies, Inc. Apr 24, 2024 4 $346K 4 Apr 25, 2024 Chairman and CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 7, 2024 8 -$4.05M 4 Mar 11, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 6, 2024 2 $0 4 Mar 8, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 1, 2024 1 $0 4 Mar 5, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2024 5 -$1.58M 4 Feb 27, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 1, 2024 3 -$2.27M 4 Feb 5, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Jan 16, 2024 13 -$9.45M 4 Jan 18, 2024 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Sep 18, 2023 3 -$5.39M 4 Sep 19, 2023 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 9, 2023 9 -$2.66M 4 Mar 13, 2023 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 6, 2023 1 $0 4 Mar 8, 2023 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2023 5 -$965K 4 Feb 27, 2023 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 18, 2023 6 -$1.3M 4 Feb 22, 2023 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Dec 13, 2022 1 -$1.82M 4 Dec 15, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 10, 2022 2 $0 4 Mar 14, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Mar 9, 2022 2 $111K 4 Mar 10, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 23, 2022 5 -$1.17M 4 Feb 25, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Feb 18, 2022 4 -$1.54M 4 Feb 23, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Jan 8, 2022 5 -$1.71M 4 Jan 11, 2022 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Oct 14, 2021 5 -$2M 4 Oct 18, 2021 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Aug 23, 2021 2 $28.4K 4 Aug 24, 2021 Chairman, President & CEO, Director
ITCI Intra-Cellular Therapies, Inc. Jan 4, 2016 1 $0 4/A Jul 7, 2023 Chairman, President & CEO, Director